Zobrazeno 1 - 10
of 793
pro vyhledávání: '"Masahiko, Mori"'
Autor:
Masahiko Mori, Kazuaki Yokoyama, Riri Sanuki, Fumio Inoue, Takafumi Maekawa, Tadayoshi Moriyama
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-8 (2024)
Abstract Background Demand for COVID-19 testing prompted the implementation of drive-through testing systems. However, limited research has examined factors influencing testing positivity in this setting. Methods From October 2020 to March 2023, a to
Externí odkaz:
https://doaj.org/article/ae9ae9628b7f4a72a3f55910b2277694
Autor:
Masahiko Mori, Aiko Yokoyama, Ayami Shichida, Kimiko Sasuga, Takafumi Maekawa, Tadayoshi Moriyama
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract In mRNA COVID-19 vaccination, side effects after the first and second dose have been well reported. However, studies about side effects after booster vaccine are sparse. 272 healthcare workers who received the third mRNA COVID-19 vaccine wer
Externí odkaz:
https://doaj.org/article/84d5d82f39da40bbb838c30ab93caeaa
Autor:
Masahiko Mori, Aiko Yokoyama, Ayami Shichida, Kimiko Sasuga, Takafumi Maekawa, Tadayoshi Moriyama
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT mRNA COVID-19 vaccination was initiated worldwide in late 2020, and its efficacy has been well reported. However, studies about vaccine-related side effects are sparse. A total of 262 health care workers who received mRNA COVID-19 vaccine BN
Externí odkaz:
https://doaj.org/article/2365bfa38bd14d39adcfd90d421334ba
Autor:
Takeshi Tanaka, Masahiko Mori, Motohiro Sekino, Ushio Higashijima, Masahiro Takaki, Yoshiro Yamashita, Satoshi Kakiuchi, Masato Tashiro, Konosuke Morimoto, Osamu Tasaki, Koichi Izumikawa
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Septic shock is characterized by dysregulated vascular permeability. We hypothesized that the vascular permeability of endothelial cells (ECs) would be regulated by serotonin via serotonin-Rho-associated kinase (ROCK) signaling. We aimed to
Externí odkaz:
https://doaj.org/article/8a138fd391aa49a0b38ffb1150730c77
Autor:
Modester Kachapila, Yuki Horiuchi, Hidetaka Nagasawa, Noe Michihata, Toru Yoshida, Yuta Kato, Paul C. Bethke, Kiyoaki Kato, Masahiko Mori
Publikováno v:
Agriculture, Vol 13, Iss 7, p 1305 (2023)
Increasing the epicotyl length (ECL) of adzuki bean cultivars enhances the suitability for mechanical weeding during the vegetative stages and harvesting at pod maturity. To explore the genetic control of ECL, and to identify molecular markers that c
Externí odkaz:
https://doaj.org/article/bea4d0e73c534768beb1c2d0f1346a35
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 2 (2022)
ABSTRACT Relebactam is a novel β-lactamase inhibitor of Ambler class A and C β-lactamases that has been developed in combination with imipenem/cilastatin for the treatment of carbapenem-resistant bacterial infections. In this study, we evaluated th
Externí odkaz:
https://doaj.org/article/285be98a95104f62a71b6a64f7216ff1
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Acute respiratory distress syndrome (ARDS) is characterized by dysregulated vascular permeability. The clinical outcomes remain poor, and the disease burden is widespread. We demonstrated that plasma 5-hydroxyindoleacetic acid (5-HIAA), a serotonin m
Externí odkaz:
https://doaj.org/article/f73c6ab3d8234c95b6b3f9c0d57b0273
Publikováno v:
Gynecologic Oncology Reports, Vol 38, Iss , Pp 100895- (2021)
Ewing’s sarcoma family tumors of the uterine cervix are extremely rare and, thus, an optimal treatment strategy has not yet been established. To the best of our knowledge, 28 cases were reported in the English literature between 1996 and 2020, and
Externí odkaz:
https://doaj.org/article/285d842f692f4db2ba20e96ddfa048e4
Autor:
Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto, Masahiko Mori, Yasuyuki Hirashima, Kazuhiro Takehara, Kazuya Ariyoshi, Tomoyasu Kato, Shigehiro Yagishita, Akinobu Hamada, Mamiko Kawasaki, Satoshi Kawashima, Sawako Tomatsuri, Yukari Nagasaka, Hiroshi Yoshida, Ryunosuke Machida, Akihiro Hirakawa, Kenichi Nakamura, Kan Yonemori
Publikováno v:
Journal of Clinical Oncology. 41:2789-2799
PURPOSE To investigate the efficacy and safety of trastuzumab deruxtecan, an antibody-drug conjugate targeting human epidermal growth factor receptor 2 (HER2) with a topoisomerase I inhibitor payload, in patients with uterine carcinosarcoma (UCS) exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e134da79f4b01eb26c814bc2c81100a3
https://doi.org/10.1200/jco.22.02558
https://doi.org/10.1200/jco.22.02558
Autor:
Yusuke Kajimoto, Kazunori Honda, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takashi Shibutani, Shoji Nagao, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Keiichi Fujiwara, Ataru Igarashi
Publikováno v:
International Journal of Clinical Oncology. 28:454-467
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12f12a4b1c99400e8acedd6f300ca2e8
https://doi.org/10.1007/s10147-023-02294-1
https://doi.org/10.1007/s10147-023-02294-1